Editorial takes aim at aggressive breast cancer screening

Has overuse of mammography created an epidemic of breast cancer pseudo-survivorship? That was the provocative question asked in a recent editorial published by Forbes.

Written by Peter Ubel, MD, physician and behavioral scientist at Duke University who focuses on medical controversies and bioethics, the editorial is a follow-up to the recent JAMA Oncology study that found patients with ductal carcinoma in situ who were aggressively treated with radiotherapy or mastectomy did not see lower breast cancer mortality rates.

Ubel underscored his point by relaying the story of a woman who underwent a botched wire biopsy that lasted more than two hours and resulted in significant pain.

Take a look at the full article at the link below. What do you think of Ubel’s assessment?

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.